Skip to main content

Table 1 General characteristics of 961 NSCLC patients

From: Serum cholinesterase may independently predict prognosis in non-small-cell lung cancer

Characteristics

All patients (N = 961)

The lower group

The higher group

p value

(ChE < 7700 U/L, N = 482)

(ChE > = 7700 U/L, N = 479)

 

Sex

 Female

340 (35.40)c

136 (28.20)c

204 (42.60)c

< 0.001

 Male

621 (64.60)c

346 (71.80)c

275 (57.40)c

 

Age at diagnosis (Years)

61.15 (10.67)a

63.10 (10.92)a

59.18 (10.04)a

< 0.001

Ethnicity

 Minority

89 (9.30)c

55 (11.40)c

34 (7.10)c

0.041

 Han majority

872 (90.70)c

427 (88.60)c

445 (92.90)c

 

Smoking

 No

384 (40.00)c

169 (35.10)c

215 (44.90)c

0.003

 Yes

577 (60.00)c

313 (64.90)c

264 (55.10)c

 

BMI (kg/m2)

23.74 (35.88)a

24.36 (50.63)a

23.14 (6.58)a

0.603

Chemotherapy

 No

443 (46.10)c

239 (49.60)c

204 (42.60)c

0.035

 Yes

518 (53.90)c

243 (50.40)c

275 (57.40)c

 

Complications

 No

521 (54.20)c

262 (54.40)c

259 (54.10)c

0.981

 Yes

440 (45.80)c

220 (45.60)c

220 (45.90)c

 

Histological type

 Adenocarcinoma

628 (65.30)c

283 (58.70)c

345 (72.00)c

< 0.001

 Squamous cell carcinoma

291 (30.30)c

177 (36.70)c

114 (23.80)c

 

 Large cell carcinoma

8 (0.80)c

6 (1.20)c

2 (0.40)c

 

 Multiple types

34 (3.50)c

16 (3.30)c

18 (3.80)c

 

Stage

 Early stage

84 (8.70)c

29 (6.00)c

55 (11.50)c

0.004

 Advanced stage

877 (91.30)c

453 (94.00)c

424 (88.50)c

 

Survival length (Day)

374.00 (147.00, 717.00)b

276.74 (107.00, 587.75)b

483.43 (219.00, 841.50)b

< 0.001

ALB (U/L)

42.50 (38.57, 45.20)b

39.95 (35.86, 42.99)b

44.19 (42.10, 46.60)b

< 0.001

NLR (Unit free)

2.95 (1.97, 4.36)b

3.43 (2.22, 5.20)b

2.53 (1.83, 3.46)b

< 0.001

ChE (U/L)

7700.00 (6287.00, 8900.00)b

–

–

 
  1. aMean with standard deviation (SD)
  2. bMedian with interquartile range (IQR)
  3. cFrequency with proportion (%)